Risk of Malignancy, Major Adverse Cardiovascular Events, and Liver Injury in Patients with Ulcerative Colitis Treated with Mirikizumab versus Other Biologics: A Secondary Database Study in Japan First published 27/05/2026 Last updated 27/05/2026 EU PAS number:EUPAS1000001009 Study Planned